# NovoSeven RT

NDC: 0169-7202
Generic name: Coagulation Factor VIIa (Recombinant)
Labeler / Manufacturer: Novo Nordisk
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20121029

FDA application: BLA103665

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-7202"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-7202